EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.5.1.28 | (R,S)-2,3-Diaminopropionic acid + pyruvate + NADH |
9.67% of the activity with S: (S)-norvaline |
Arthrobacter sp. |
? |
- |
? |
1.5.1.28 | (R,S)-3-Aminobutanoate + pyruvate + NADH |
0.68% of the activity with (S)-norvaline |
Arthrobacter sp. |
N-[1-(R)-(Carboxy)ethyl]-(R,S)-3-aminobutanoate + NAD+ |
- |
? |
1.5.1.28 | (S)-2-aminobutyric acid + pyruvate + NADH |
83.7% of the activity with (S)-norvaline |
Arthrobacter sp. |
N-[1-(R)-(carboxy)ethyl]-(S)-2-aminobutyric acid + NAD+ |
- |
? |
1.5.1.28 | (S)-2-aminobutyric acid + pyruvate + NADH |
83.7% of the activity with (S)-norvaline |
Arthrobacter sp. 1C |
N-[1-(R)-(carboxy)ethyl]-(S)-2-aminobutyric acid + NAD+ |
- |
? |
1.5.1.28 | (S)-Norleucine + pyruvate + NADH |
72.5% of the activity with (S)-norvaline |
Arthrobacter sp. |
N-[1-(R)-(Carboxy)ethyl]-norleucine + NAD+ |
- |
? |
1.5.1.28 | (S)-Norleucine + pyruvate + NADH |
72.5% of the activity with (S)-norvaline |
Arthrobacter sp. 1C |
N-[1-(R)-(Carboxy)ethyl]-norleucine + NAD+ |
- |
? |
1.5.1.28 | (S)-Norvaline + pyruvate + NADH |
- |
Arthrobacter sp. |
N-[1-(R)-(Carboxy)ethyl]-(S)-norvaline + NAD+ |
- |
? |
1.5.1.28 | (S)-Norvaline + pyruvate + NADH |
- |
Arthrobacter sp. 1C |
N-[1-(R)-(Carboxy)ethyl]-(S)-norvaline + NAD+ |
- |
? |
1.5.1.28 | (S)-Phenylalaninol + pyruvate + NADH |
0.63% of the activity with (S)-norvaline |
Arthrobacter sp. |
N-[1-(R)-(Carboxy)ethyl]-(S)-phenylalaninol + NAD+ |
- |
? |
1.5.1.28 | (S)-Phenylglycine + pyruvate + NADH |
4.4% of the activity with (S)-norvaline |
Arthrobacter sp. |
N-[1-(R)-(Carboxy)ethyl]-(S)-phenylglycine + NAD+ |
- |
? |